Pfizer Inc.
PFE
$22.28
-$0.26-1.15%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.88B | 8.03B | 4.25B | -2.60B | -309.00M |
| Total Depreciation and Amortization | 6.88B | 6.99B | 6.87B | 6.68B | 6.52B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 879.00M | 785.00M | -2.32B | 3.54B | 2.37B |
| Change in Net Operating Assets | -1.65B | -3.07B | 2.46B | 380.00M | -1.00M |
| Cash from Operations | 13.99B | 12.74B | 11.26B | 8.01B | 8.58B |
| Capital Expenditure | -2.77B | -2.91B | -3.04B | -3.20B | -3.47B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -43.41B | -43.41B | -43.43B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.96B | 5.56B | 39.72B | 42.82B | 13.04B |
| Cash from Investing | 4.19B | 2.65B | -6.72B | -3.78B | -33.86B |
| Total Debt Issued | 7.46B | 8.91B | 15.85B | 13.66B | 39.72B |
| Total Debt Repaid | -14.88B | -16.07B | -12.51B | -9.51B | -5.92B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.58B | -9.51B | -9.45B | -9.38B | -9.32B |
| Other Financing Activities | -439.00M | -469.00M | -473.00M | -504.00M | -582.00M |
| Cash from Financing | -17.44B | -17.14B | -6.58B | -5.73B | 23.91B |
| Foreign Exchange rate Adjustments | -45.00M | -66.00M | -38.00M | -79.00M | -66.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | 0.00 | 0.00 | 3.00M | 1.00M |
| Net Change in Cash | 701.00M | -1.81B | -2.08B | -1.57B | -1.44B |